323 research outputs found

    Neuropsychiatric Complications of HIV Infection: Public Policy Implications

    Get PDF
    The human immunodeficiency virus (HIV) infects the central nervous system (CNS), causing symptoms in most persons with AIDS-related complex (ARC) and AIDS, and in a significant proportion of those classified as asymptomatic seropositive. The most common clinical syndrome secondary to CNS infection is known as HIV encephalopathy. When sufficiently disabling, HIV encephalopathy is known as AIDS dementia, and must be reported to the Centers for Disease Control as a case of AIDS. AIDS dementia is a complex of cognitive, affective, behavioral, and motor symptoms which varies widely in its presentation. In some persons, cognitive impairment predominates, manifesting in a loss of intellectual capacities such as short-term memory, information processing, and abstract thinking. When mood disturbance predominates, it may present as irritability, anxiety, depression, or mania. Behavioral complications are most often due to confusion or psychosis, and may render the patient difficult for caretakers to manage. Motor impairments include slowing, gait abnormalities, incontinence, and paralysis. AIDS dementia presents a significant challenge to the public health system. Physicians, other health providers, and policymakers must be educated so that they may tackle the problems of diagnosis, acute and chronic care, and public safety which are related to this illness

    Factors Affecting Treatment Discontinuation and Treatment Outcome in Patients with Schizophrenia in Korea: 10-Year Follow-Up Study

    Get PDF
    ObjectiveaaThere have been few long-term studies that have assessed factors influencing treatment discontinuation and long-term out-come of schizophrenia in Korea. The present study aimed to evaluate factors affecting treatment discontinuation and treatment outcome, after 10 years, in patients with schizophrenia. MethodsaaAmong hospitalized patients between 1997 and 1999, 191 patients were given continuous follow-up service. We examined the clinical characteristics and outcome of patients who remained in treatment. Regression analyses were used to find any clinical factors affecting treatment discontinuation. ResultsaaOne hundred thirty-three patients (71.12%) discontinued the treatment. The treatment retention group contained more female patients, paranoid-type patients, patients who had shown self-harming behavior, patients receiving clozapine, and patients with good medication compliance. The recovery rate was 25%. However, 42.3 % did not have gainful employment. Further, most patients couldn’t live independently. ConclusionaaThe results show the importance of gender, patient behavior, medication, and medication compliance in predicting treat-ment discontinuation in patients with schizophrenia. Psychiatry Investig 2011;8:22-2

    EEG Multiscale Complexity in Schizophrenia During Picture Naming

    Get PDF
    We aimed to investigate changes in non-linear brain dynamics of patients with schizophrenia during cognitive processing. As expected, controls had fewer naming errors than patients. Regarding EEG complexity, the interaction between Group, Task and ROI indicated that patients showed higher complexity values in right frontal regions only at rest, where no differences in complexity between patients and controls were found during the naming task. EEG complexity increased from rest to task in controls in left temporal-parietal regions, while no changes from rest to task were observed in patients. Finally, differences in complexity between patients and controls depended on the frequency bands: higher values of complexity in patients at rest were only observed in fast bands, indicating greater heterogeneity in patients in local dynamics of neuronal assemblies. Consistent with previous studies, schizophrenic patients showed higher complexity than controls in frontal regions at rest. Interestingly, we found different modulations of brain complexity during a simple cognitive task between patients and controls. These data can be interpreted as indicating schizophrenia-related failures to adapt brain functioning to the task, which is reflected in poorer behavioral performance.This research was supported by Junta de Andalucía (Biomedical and Health Science Research Project PI-0410-2014 to MS and PI-0386-2016 to S. Iglesias-Parro); and Ministerio de Economía, industria y competitividad (PSI2015-65502-C2-1-P to MB and PSI2015-65502-C2-2-P to CG-A)

    Longitudinal consent-related abilities among research participants with schizophrenia: Results from the CATIE study

    Get PDF
    Research participants must have adequate consent-related abilities to provide informed consent at the time of study enrollment. We sought to determine if research participants with schizophrenia maintain adequate consent-related abilities during a longitudinal study. If participants lose abilities during a trial they may not be able to judge and protect their interests. If reduced abilities are common or can be predicted, special protections can be targeted appropriately
    corecore